Post on 23-May-2020
ABcomm, Inc.PO Box 7046Champaign, IL 61826-7046
FORT LAUDERDALE
CYSTIC FIBROSIS
CURRENT TRENDS ANDFUTURE DIRECTIONSSU
MM
IT
JERSEY CITY
CYSTIC FIBROSIS
CURRENT TRENDS ANDFUTURE DIRECTIONSSU
MM
IT
SAN FRANCISCO
CYSTIC FIBROSIS
CURRENT TRENDS ANDFUTURE DIRECTIONSSU
MM
IT
Supported by an independent educational grant from Gilead Sciences Medical Affairs.
FORT LAUDERDALE
CYSTIC FIBROSIS
CURRENT TRENDS ANDFUTURE DIRECTIONSSU
MM
IT
JERSEY CITY
CYSTIC FIBROSIS
CURRENT TRENDS ANDFUTURE DIRECTIONSSU
MM
IT
SAN FRANCISCO
CYSTIC FIBROSIS
CURRENT TRENDS ANDFUTURE DIRECTIONSSU
MM
IT
Provided by ABcomm, Inc.
Saturday, October 14, 2017 • 8:00 am – 2:30 pmThe Westin Fort Lauderdale • 400 Corporate DriveFort Lauderdale, FL
OCT
14
Saturday, October 14, 20178:00 am – 2:30 pmThe Westin Fort Lauderdale 400 Corporate DriveFort Lauderdale, FL
Dear Colleague,
We are pleased to invite you to a very exciting and intensive accredited educational activity designed specifically for physicians and advanced practitioners involved in the management and treatment of patients with cystic fibrosis. During this half-day course, we will discuss the clinical impact of consequential respiratory pathogens, review long-term treatment data, examine the role of CFTR modulators, and discuss the impact of clinical comorbidities such as nutritional deficits and mental health issues.
We will also interview a patient with cystic fibrosis and then collaborate on strategies to improve patient and family education, ensure smooth transitioning from pediatric to adult care, and develop techniques to help our patients improve their adherence to treatment.
This educational activity is designed to be highly interactive in nature and is limited to a small number of participants. Please plan to register soon. We look forward to seeing you!
Matthias A. Salathe, MDProgram Chairman
Peter J. Mogayzel, Jr., MD, PhDProfessor of PediatricsDirector, Cystic Fibrosis CenterJohns Hopkins School of MedicineBaltimore, MD
Carlos E. Milla, MDAssociate Professor of Pediatrics – Pulmonary MedicineDirector, The Stanford Cystic Fibrosis CenterAssociate Director for Translational ResearchCenter for Excellence in Pulmonary BiologyStanford University School of MedicinePalo Alto, CA
FORT LAUDERDALE
CYSTIC FIBROSIS
CURRENT TRENDS ANDFUTURE DIRECTIONSSU
MM
IT
JERSEY CITY
CYSTIC FIBROSIS
CURRENT TRENDS ANDFUTURE DIRECTIONSSU
MM
ITSAN FRANCISCO
CYSTIC FIBROSIS
CURRENT TRENDS ANDFUTURE DIRECTIONSSU
MM
IT
FORT LAUDERDALE
CYSTIC FIBROSIS
CURRENT TRENDS ANDFUTURE DIRECTIONSSU
MM
IT
JERSEY CITY
CYSTIC FIBROSIS
CURRENT TRENDS ANDFUTURE DIRECTIONSSU
MM
IT
SAN FRANCISCO
CYSTIC FIBROSIS
CURRENT TRENDS ANDFUTURE DIRECTIONSSU
MM
IT
Matthias A. Salathe, MDProgram ChairmanProfessor of MedicineChief, Division of Pulmonary & Critical Care MedicineUniversity of Miami School of MedicineDirector, Adult Cystic Fibrosis CenterUniversity of MiamiMiami, FL
PROGRAM AGENDA
8:00 am – 8:30 am CME Registration / Continental Breakfast
8:30 am – 8:45 am Welcome and Introductions Matthias A. Salathe, MD
8:45 am – 9:30 am Real World Experience: A Patient’s Perspective / Patient Interview
9:30 am – 10:00 am The Current Lay of the Land Matthias A. Salathe, MD
10:00 am – 10:15 am Break
10:15 am – 11:15 am The Big Picture – Infection Prevention to Chronic Suppression
Peter J. Mogayzel, Jr., MD, PhD
11:15 am – 12:00 pm CFTR Modulation – Where We Are and Where We Are Headed
Carlos E. Milla, MD
12:00 pm – 1:15 pm Lunch / Breakout Session All Faculty
1:15 pm – 1:45 pm Pediatric to Adult Care – Easing the Transition Carlos E. Milla, MD
1:45 pm – 2:15 pm Adherence – Overcoming Obstacles on the Road to Success
Peter J. Mogayzel, Jr., MD, PhD
2:15 pm – 2:30 pm Concluding Remarks and Evaluation Matthias A. Salathe, MD
LEARNING OBJECTIVESAs a result of attending this activity, participants will be able to: Describe the clinical relevance and changing epidemiology of
consequential respiratory pathogens. Select aerosolized antibiotics by comparing safety, efficacy, and
long-term study data, and monitor outcomes for necessary treatment adjustments.
Describe the evolution of CFTR modulators and decide when they are an appropriate addition to the treatment plan based on patient specific criteria including mutation analysis.
Assess the impact of nutrition management, mental health screening, and treatment of comorbid conditions on overall patient outcomes.
Outline current recommendations for transfer from the pediatric to the adult care setting.
Appreciate the number and complexity of treatments, and involve patients and/or family in treatment management decisions to improve adherence.
ACCREDITATION ABcomm, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
CREDIT DESIGNATIONABcomm, Inc. designates this educational activity for a maximum of 5.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity. Participants must complete and submit an activity evaluation form in order to receive a certificate of credit. Certificates will be mailed to participants 4-6 weeks after the activity.
Saturday, October 14, 2017 • 8:00 am – 2:30 pmThe Westin Fort Lauderdale • 400 Corporate Drive Fort Lauderdale, FL
DISCLOSURE STATEMENTIt is the policy and practice of ABcomm, Inc. to resolve all potential conflicts of interest prior to activities. This information will be made available to participants at the beginning of the activity.
REGISTRATION PROCEDURE Registrations will be accepted through Friday, October 6, 2017 or until the maximum enrollment is reached. Enrollment is limited to 25 participants.
Registrations can be submitted using one of the following methods:
ONLINE: Go to www.cfsummitfortlauderdale.eventbrite.com
TELEPHONE: Contact us at (217) 607-1285 during regular business hours.
FAX / SCAN: Complete the written application form and email to LValentine@ABcomminc.com or fax to (866) 266-9741.
MAIL: Send application form with check payable to ABcomm, Inc. or credit card information to ABcomm, Inc., PO Box 7046, Champaign, IL 61826.
FEEThe registration fee for Cystic Fibrosis Summit: Current Trends and Future Directions is $30. This fee includes all educational materials, planned group meal functions, and CME certificate. Participants are responsible for their own travel, parking, and lodging expenses.
REFUND POLICYYour registration fee will be fully refunded if your application is not accepted due to space limitations. In the event that you need to cancel, one-half of your registration fee ($15) will be refunded if written notification is received by October 6, 2017.
LODGINGThe Westin Fort Lauderdale400 Corporate DriveFort Lauderdale, FL 33334(954) 772-1331
Free parking is available.
OTHER INFORMATION
WHAT IS YOUR AREA OF SPECIALTY? PULMONOLOGY PEDIATRIC PULMONOLOGY PEDIATRICS INTERNAL MEDICINE CRITICAL CARE OTHER
ARE YOU BOARD CERTIFIED? YES NO YEARS IN PRACTICE
ON AVERAGE, HOW MANY PATIENTS WITH CF DO YOU TREAT PER WEEK?
HOW DID YOU LEARN ABOUT THIS ACTIVITY? EMAIL BROCHURE OR LETTER IN MAIL COLLEAGUE
WHAT DO YOU HOPE TO GAIN FROM ATTENDING THIS ACTIVITY?
IDENTIFY THE BIGGEST BARRIER TO IMPLEMENTING CHANGES IN YOUR PRACTICE:
IF YOU HAVE ANY SPECIAL NEEDS OR DIETARY RESTRICTIONS FOR THIS ACTIVITY, PLEASE SPECIFY:
FIRST NAME LAST NAME DEGREE(S)
TITLE INSTITUTION
ADDRESS CITY STATE
ZIP PHONE EMAIL
PAYMENT INFORMATION
Visa MasterCard American Express Discover Check (mailed with registration form)
CARD NUMBER EXPIRATION DATE 3 – 4 DIGIT SECURITY CODE
BILLING ADDRESS
REGISTRATION FORM
BOSTON
CYSTIC FIBROSIS
CURRENT TRENDS ANDFUTURE DIRECTIONSSU
MM
IT
NEW ENGLAND
CYSTIC FIBROSIS
CURRENT TRENDS ANDFUTURE DIRECTIONSSU
MM
IT
WEST COAST
CYSTIC FIBROSIS
CURRENT TRENDS ANDFUTURE DIRECTIONSSU
MM
IT
REGISTRATION DEADLINE: FRIDAY, OCTOBER 6, 2017
Register online at www.cfsummitfortlauderdale.eventbrite.com
REGISTER ONLINE ATwww.cfsummitfortlauderdale.eventbrite.com
FORT LAUDERDALE
CYSTIC FIBROSIS
CURRENT TRENDS ANDFUTURE DIRECTIONSSU
MM
IT
JERSEY CITY
CYSTIC FIBROSIS
CURRENT TRENDS ANDFUTURE DIRECTIONSSU
MM
IT
SAN FRANCISCO
CYSTIC FIBROSIS
CURRENT TRENDS ANDFUTURE DIRECTIONSSU
MM
IT
FORT LAUDERDALE
CYSTIC FIBROSIS
CURRENT TRENDS ANDFUTURE DIRECTIONSSU
MM
IT
JERSEY CITY
CYSTIC FIBROSIS
CURRENT TRENDS ANDFUTURE DIRECTIONSSU
MM
IT
SAN FRANCISCO
CYSTIC FIBROSIS
CURRENT TRENDS ANDFUTURE DIRECTIONSSU
MM
IT
PROGRAM AGENDA
8:00 am – 8:30 am CME Registration / Continental Breakfast
8:30 am – 8:45 am Welcome and Introductions Matthias A. Salathe, MD
8:45 am – 9:30 am Real World Experience: A Patient’s Perspective / Patient Interview
9:30 am – 10:00 am The Current Lay of the Land Matthias A. Salathe, MD
10:00 am – 10:15 am Break
10:15 am – 11:15 am The Big Picture – Infection Prevention to Chronic Suppression
Peter J. Mogayzel, Jr., MD, PhD
11:15 am – 12:00 pm CFTR Modulation – Where We Are and Where We Are Headed
Carlos E. Milla, MD
12:00 pm – 1:15 pm Lunch / Breakout Session All Faculty
1:15 pm – 1:45 pm Pediatric to Adult Care – Easing the Transition Carlos E. Milla, MD
1:45 pm – 2:15 pm Adherence – Overcoming Obstacles on the Road to Success
Peter J. Mogayzel, Jr., MD, PhD
2:15 pm – 2:30 pm Concluding Remarks and Evaluation Matthias A. Salathe, MD
LEARNING OBJECTIVESAs a result of attending this activity, participants will be able to: Describe the clinical relevance and changing epidemiology of
consequential respiratory pathogens. Select aerosolized antibiotics by comparing safety, efficacy, and
long-term study data, and monitor outcomes for necessary treatment adjustments.
Describe the evolution of CFTR modulators and decide when they are an appropriate addition to the treatment plan based on patient specific criteria including mutation analysis.
Assess the impact of nutrition management, mental health screening, and treatment of comorbid conditions on overall patient outcomes.
Outline current recommendations for transfer from the pediatric to the adult care setting.
Appreciate the number and complexity of treatments, and involve patients and/or family in treatment management decisions to improve adherence.
ACCREDITATION ABcomm, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
CREDIT DESIGNATIONABcomm, Inc. designates this educational activity for a maximum of 5.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity. Participants must complete and submit an activity evaluation form in order to receive a certificate of credit. Certificates will be mailed to participants 4-6 weeks after the activity.
Saturday, October 14, 2017 • 8:00 am – 2:30 pmThe Westin Fort Lauderdale • 400 Corporate Drive Fort Lauderdale, FL
DISCLOSURE STATEMENTIt is the policy and practice of ABcomm, Inc. to resolve all potential conflicts of interest prior to activities. This information will be made available to participants at the beginning of the activity.
REGISTRATION PROCEDURE Registrations will be accepted through Friday, October 6, 2017 or until the maximum enrollment is reached. Enrollment is limited to 25 participants.
Registrations can be submitted using one of the following methods:
ONLINE: Go to www.cfsummitfortlauderdale.eventbrite.com
TELEPHONE: Contact us at (217) 607-1285 during regular business hours.
FAX / SCAN: Complete the written application form and email to LValentine@ABcomminc.com or fax to (866) 266-9741.
MAIL: Send application form with check payable to ABcomm, Inc. or credit card information to ABcomm, Inc., PO Box 7046, Champaign, IL 61826.
FEEThe registration fee for Cystic Fibrosis Summit: Current Trends and Future Directions is $30. This fee includes all educational materials, planned group meal functions, and CME certificate. Participants are responsible for their own travel, parking, and lodging expenses.
REFUND POLICYYour registration fee will be fully refunded if your application is not accepted due to space limitations. In the event that you need to cancel, one-half of your registration fee ($15) will be refunded if written notification is received by October 6, 2017.
LODGINGThe Westin Fort Lauderdale400 Corporate DriveFort Lauderdale, FL 33334(954) 772-1331
Free parking is available.
OTHER INFORMATION
WHAT IS YOUR AREA OF SPECIALTY? PULMONOLOGY PEDIATRIC PULMONOLOGY PEDIATRICS INTERNAL MEDICINE CRITICAL CARE OTHER
ARE YOU BOARD CERTIFIED? YES NO YEARS IN PRACTICE
ON AVERAGE, HOW MANY PATIENTS WITH CF DO YOU TREAT PER WEEK?
HOW DID YOU LEARN ABOUT THIS ACTIVITY? EMAIL BROCHURE OR LETTER IN MAIL COLLEAGUE
WHAT DO YOU HOPE TO GAIN FROM ATTENDING THIS ACTIVITY?
IDENTIFY THE BIGGEST BARRIER TO IMPLEMENTING CHANGES IN YOUR PRACTICE:
IF YOU HAVE ANY SPECIAL NEEDS OR DIETARY RESTRICTIONS FOR THIS ACTIVITY, PLEASE SPECIFY:
FIRST NAME LAST NAME DEGREE(S)
TITLE INSTITUTION
ADDRESS CITY STATE
ZIP PHONE EMAIL
PAYMENT INFORMATION
Visa MasterCard American Express Discover Check (mailed with registration form)
CARD NUMBER EXPIRATION DATE 3 – 4 DIGIT SECURITY CODE
BILLING ADDRESS
REGISTRATION FORM
BOSTON
CYSTIC FIBROSIS
CURRENT TRENDS ANDFUTURE DIRECTIONSSU
MM
IT
NEW ENGLAND
CYSTIC FIBROSIS
CURRENT TRENDS ANDFUTURE DIRECTIONSSU
MM
IT
WEST COAST
CYSTIC FIBROSIS
CURRENT TRENDS ANDFUTURE DIRECTIONSSU
MM
IT
REGISTRATION DEADLINE: FRIDAY, OCTOBER 6, 2017
Register online at www.cfsummitfortlauderdale.eventbrite.com
REGISTER ONLINE ATwww.cfsummitfortlauderdale.eventbrite.com
FORT LAUDERDALE
CYSTIC FIBROSIS
CURRENT TRENDS ANDFUTURE DIRECTIONSSU
MM
IT
JERSEY CITY
CYSTIC FIBROSIS
CURRENT TRENDS ANDFUTURE DIRECTIONSSU
MM
IT
SAN FRANCISCO
CYSTIC FIBROSIS
CURRENT TRENDS ANDFUTURE DIRECTIONSSU
MM
IT
FORT LAUDERDALE
CYSTIC FIBROSIS
CURRENT TRENDS ANDFUTURE DIRECTIONSSU
MM
IT
JERSEY CITY
CYSTIC FIBROSIS
CURRENT TRENDS ANDFUTURE DIRECTIONSSU
MM
IT
SAN FRANCISCO
CYSTIC FIBROSIS
CURRENT TRENDS ANDFUTURE DIRECTIONSSU
MM
IT
ABcomm, Inc.PO Box 7046Champaign, IL 61826-7046
FORT LAUDERDALE
CYSTIC FIBROSIS
CURRENT TRENDS ANDFUTURE DIRECTIONSSU
MM
IT
JERSEY CITY
CYSTIC FIBROSIS
CURRENT TRENDS ANDFUTURE DIRECTIONSSU
MM
IT
SAN FRANCISCO
CYSTIC FIBROSIS
CURRENT TRENDS ANDFUTURE DIRECTIONSSU
MM
IT
Supported by an independent educational grant from Gilead Sciences Medical Affairs.
FORT LAUDERDALE
CYSTIC FIBROSIS
CURRENT TRENDS ANDFUTURE DIRECTIONSSU
MM
IT
JERSEY CITY
CYSTIC FIBROSIS
CURRENT TRENDS ANDFUTURE DIRECTIONSSU
MM
IT
SAN FRANCISCO
CYSTIC FIBROSIS
CURRENT TRENDS ANDFUTURE DIRECTIONSSU
MM
IT
Provided by ABcomm, Inc.
Saturday, October 14, 2017 • 8:00 am – 2:30 pmThe Westin Fort Lauderdale • 400 Corporate DriveFort Lauderdale, FL
OCT
14
Saturday, October 14, 20178:00 am – 2:30 pmThe Westin Fort Lauderdale 400 Corporate DriveFort Lauderdale, FL
Dear Colleague,
We are pleased to invite you to a very exciting and intensive accredited educational activity designed specifically for physicians and advanced practitioners involved in the management and treatment of patients with cystic fibrosis. During this half-day course, we will discuss the clinical impact of consequential respiratory pathogens, review long-term treatment data, examine the role of CFTR modulators, and discuss the impact of clinical comorbidities such as nutritional deficits and mental health issues.
We will also interview a patient with cystic fibrosis and then collaborate on strategies to improve patient and family education, ensure smooth transitioning from pediatric to adult care, and develop techniques to help our patients improve their adherence to treatment.
This educational activity is designed to be highly interactive in nature and is limited to a small number of participants. Please plan to register soon. We look forward to seeing you!
Matthias A. Salathe, MDProgram Chairman
Peter J. Mogayzel, Jr., MD, PhDProfessor of PediatricsDirector, Cystic Fibrosis CenterJohns Hopkins School of MedicineBaltimore, MD
Carlos E. Milla, MDAssociate Professor of Pediatrics – Pulmonary MedicineDirector, The Stanford Cystic Fibrosis CenterAssociate Director for Translational ResearchCenter for Excellence in Pulmonary BiologyStanford University School of MedicinePalo Alto, CA
FORT LAUDERDALE
CYSTIC FIBROSIS
CURRENT TRENDS ANDFUTURE DIRECTIONSSU
MM
IT
JERSEY CITY
CYSTIC FIBROSIS
CURRENT TRENDS ANDFUTURE DIRECTIONSSU
MM
IT
SAN FRANCISCO
CYSTIC FIBROSIS
CURRENT TRENDS ANDFUTURE DIRECTIONSSU
MM
IT
FORT LAUDERDALE
CYSTIC FIBROSIS
CURRENT TRENDS ANDFUTURE DIRECTIONSSU
MM
IT
JERSEY CITY
CYSTIC FIBROSIS
CURRENT TRENDS ANDFUTURE DIRECTIONSSU
MM
IT
SAN FRANCISCO
CYSTIC FIBROSIS
CURRENT TRENDS ANDFUTURE DIRECTIONSSU
MM
IT
Matthias A. Salathe, MDProgram ChairmanProfessor of MedicineChief, Division of Pulmonary & Critical Care MedicineUniversity of Miami School of MedicineDirector, Adult Cystic Fibrosis CenterUniversity of MiamiMiami, FL